Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2).

Eric L SimpsonPablo Fernández-PeñasMarjolein de Bruin-WellerPeter A LioChia-Yu ChuKhaled EzzedineHelena AgellMarta CasillasYuxin DingFan Emily YangEvangeline PierceThomas Bieber

Published in: Advances in therapy (2024)

ClinicalTrials.gov identifiers, NCT04146363; NCT04178967.

Keyphrases

placebo controlled
double blind
atopic dermatitis
phase iii
clinical trial
phase ii
study protocol
phase ii study
open label
combination therapy
randomized controlled trial
radiation therapy
squamous cell carcinoma